About Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.
Founded
1978
CEO
Harsha Raghavan
Employees
1,410
HQ
Gurgaon, India
Finished Products
1Formulation
₹263.41Cr2Sales of Products
₹236.71Cr3Revenue from Operations
₹208.70Cr4Active Pharmaceutical Ingredie
₹5.31CrRaw Materials
1Purchase of Stock in Trade
₹191.03Cr2RM Consumed
₹40.44Cr3Raw Material Consumed
₹31.21CrAbout Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.
Founded:1978
CEO:Harsha Raghavan
Employees:1,410
HQ:Gurgaon, India
Finished Products
1Formulation
₹263.41Cr2Sales of Products
₹236.71Cr3Revenue from Operations
₹208.70Cr4Active Pharmaceutical Ingredie
₹5.31CrRaw Materials
1Purchase of Stock in Trade
₹191.03Cr2RM Consumed
₹40.44Cr3Raw Material Consumed
₹31.21CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹265
52W Low
₹155
Volume58.88K
Avg VolumeN/A
Beta0.63
Dividend Yield1.71%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
34.40x
Valuation
P/B Ratio
5.67x
Valuation
EPS
₹6.89
Valuation
Dividend Yield
1.71%
Valuation
ROE
15.60%
Profitability
ROCE
20.59%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals businessRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.03x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.